Metabolomics: Reversing drug resistance
14 Sep 2016
Metabolomics: Reversing drug resistance
Developing new models in SCLC
Future of imaging in lung cancer
ß1 integrins and DNA repair for radiosensitization of head and neck cancer
Cancer organoids
Editor's Choice for June 2016
Editor's ASCO 2016 Roundup
Targeted genome editing in haematopoeitic stem cells
A microRNA driver of B-cell leukaemia
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients
Killer antibodies against AML
Multiple myeloma highlights from EHA 2016